Early effects of irradiation on [123I]-IMT and [ 18F]-FDG uptake in rat C6 glioma cells

Strahlentherapie und Onkologie

Volumn 180, Issue 7, 2004, Pages 434-441

  Riemann, Burkhard ^a   Könemann, Stefan ^a   Pöpping, Daniel ^a   Kopka, Klaus ^a   Weckesser, Matthias ^a   Willich, Normann ^a   Schober, Otmar ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

123I IMT; 18F FDG; C6 glioma cells; Irradiation; PET; SPECT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 123; IODOTYROSINE;

ANIMAL CELL; ARTICLE; CANCER GRADING; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; GIANT CELL; GLIOMA; INTRAOPERATIVE PERIOD; MICROMORPHOLOGY; MORPHOMETRICS; NONHUMAN; RADIATION DOSE DISTRIBUTION; RADIATION NECROSIS; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BIOLOGICAL TRANSPORT; CELL DIVISION; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; GLIOMA; IODINE RADIOISOTOPES; METHYLTYROSINES; RADIOPHARMACEUTICALS; RATS;

EID: 4444231809     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1232-3     Document Type: Article

References (66)

1. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma - a predictor of prognosis. Cancer 1988;62:1074-8.
2. Amano T, Hamprecht B, Kemper W. High activity of choline acetyltransferase induced in neuroblastoma x glia hybrid cells. Exp Cell Res 1974; 85:399-408.
3. 18F] fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy. Eur J Nucl Med 1999;26:144-51.
4. Bassa P, Kim EE, Inoue T, et al. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer. J Nucl Med 1996;37:931-8.
5. 123I]iodo-α-methyltyrosine and SPECT. J Nucl Med 1989;30:110-2.
6. Coleman RE, Hoffman JM, Hanson MW, et al. Clinical application of PET for the evaluation of brain tumors. J Nucl Med 1991;32:616-22.
7. 11C]tyrosine and fluorine-18-fluorodeoxyglucose. J Nucl Med 1992;33:373-9.
8. Delbeke D, Meyerowitz C, Lapidus RL, et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995;195:47-52.
9. Di Chiro G, DeLaPaz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by 18-F-fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-9.
10. Fujibayashi Y, Waki A, Sakahara H, et al. Transient increase in glycolytic metabolism in cultured tumor cells immediately after exposure to ionizing radiation: from gene expression to deoxyglucose uptake. Radiat Res 1997; 147:729-34.
11. Gerlach B, Harder AH, Hulsebos TJM, et al. Radiosensitivity and TP53, EGFR amplification and LOH10 analysis of primary glioma cell cultures. Strahlenther Onkol 2002;178:491-6.
12. 18F] fluorodeoxyglucose positron emission tomography. Ann Neurol 1991;29:347-55.
13. Grosu AL, Feldmann HJ, Dick S, et al. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas. Int J Radiat Oncol Biol Phys 2002;54:842-54.
14. Grosu AL, Weber W, Feldmann HJ, et al. First experience with I-123-alpha-methyl-tyrosine SPECT in the 3-D radiation treatment planning of brain gliomas. Int J Radiat Oncol Biol Phys 2000;47:517-26.
15. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991;32:1485-90.
16. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-8.
17. Hansson L, Ohlsson T, Valind S, et al. Glucose utilization in the lungs of septic rats. Eur J Nucl Med 1999;26:1340-4.
18. Hautzel H, Müller-Gärtner HW. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 1997;38:1384-6.
19. Herholz K, Friedrichs B, Jeske J, et al. Prognostic significance of positron emission tomography with F-18-fluorodeoxyglucose in gliomas. J Cancer Res Clin Oncol 1992;118:Suppl:R119.
20. Higashi K, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-deoxy-D- glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 1993;34:773-9.
21. Hölzer T, Herholz K, Jeske J, et al. FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr 1993;17:681-7.
22. 18F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 2002;43:658-63.
23. Kawai K, Fujibayashi Y, Saji H, et al. A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-L-tyrosine. J Nucl Med 1991;32:819-24.
24. Kim CK, Alavi JB, Alavi A, et al. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol 1991;10:85-91.
25. 123I]iodo-L-alpha-methyl tyrosine transport in astrocytes of neonatal rats. J Neurochem 2001;76:97-104.
26. Kortmann RD, Timmermann B, Taylor RE, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy. Strahlenther Onkol 2003;179:509-20.
27. Krummeich C, Holschbach M, Stöcklin G. Direct n.c.a. electrophilic radioiodination of tyrosine analogues; their in vivo stability and brain-uptake in mice. Appl Radiat Isot 1994;45:929-35.
28. 3H]thymidine, and gallium-67. J Nucl Med 1991;32:2118-23.
29. Kubota K, Matsuzawa T, Takahashi T, et al. Rapid and sensitive response of carbon-11-L-methionine tumor uptake to irradiation. J Nucl Med 1989;30:2012-6.
30. Kubota R, Kubota K, Yamada S, et al. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994;35:104-12.
31. Kuwert T, Morgenroth C, Woesler B, et al. Uptake of iodine-123-α- methyl tyrosine by gliomas and non-neoplastic brain lesions. Eur J Nucl Med 1996; 23:1345-53.
32. Kuwert T, Probst-Cousin S, Woesler B, et al. Iodine-123-α-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity. J Nucl Med 1997;38:1551-5.
33. Kuwert T, Woesler B, Morgenroth C, et al. Diagnosis of recurrent glioma with SPECT and iodine-123-α-methyl tyrosine. J Nucl Med 1998;39:23-7.
34. 123I]iodo-α-methyl tyrosine: competition with natural L-amino acids. J Nucl Med 1991;32:1225-8.
35. 3H-methyl]-L-methionine. J Nucl Med 2000;41:1250-5.
36. Lutterbach J, Sauerbrei W, Guttenberger R. Multivariate analysis of prognostic factors in patients with glioblastoma. Strahlenther Onkol 2003;179:8-15.
37. Maruyama I, Sadato N, Waki A, et al. Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study. J Nucl Med 1999;40:1085-90.
38. Matheja P, Rickert C, Weckesser M, et al. Sequential scintigraphic strategy for the differentiation of brain tumours. Eur J Nucl Med 2000;27:550-8.
39. Matheja P, Weckesser M, Rickert C, et al. I-123-iodo-α-methyl tyrosine SPECT in non-parenchymal brain tumors. Nuklearmedizin 2002;41:191-6.
40. Mineura K, Sasajima T, Kowada M, et al. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 1994;73:2386-94.
41. Nusser NN, Bartkowiak D, Röttinger EM. The influence of bromodeoxyuridine on the induction and repair of DNA double-strand breaks in glioblastoma cells. Strahlenther Onkol 2002;178:504-9.
42. 11C-methionine for diagnosis of recurrent brain tumors and radiation injury. Acta Radiol 1991;32:197-202.
43. Patronas NJ, Brooks RA, DeLaPaz RL, et al. Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. AJNR 1983;4:533-5.
44. Patronas NJ, Di Chiro G, Brooks RA, et al. 18-Fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 1982;144:885-9.
45. Patronas NJ, Di Chiro G, Kufta C, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985;62:816-22.
46. Perez CA, Brady LW, eds. Principles and practice of radiation oncology. Philadelphia: Lippincott, 1987:1-48.
47. 131I-labelled monoclonal antibodies (BC-4) against tenascin for treatment of glioma (WHO III and IV). Nuklearmedizin 2002;41:120-8.
48. Puck TT, Marcus PI. Action of X-rays on mammalian cells. J Exp Med 1956; 103:653-69.
49. 123I]IMT) transport in human GOS3 glioma cells. Nucl Med Biol 2001;28:293-7.
50. 123I-IMT SPECT. Radiology 2002;225:567-74.
51. 123I]iodo-L-α-methyltyrosine transport in rat C6 glioma cells. Eur J Nucl Med 1999;26:1274-8.
52. Rozental JM, Levine RL, Mehta MP, et al. Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1991;20:1053-60.
53. Scharko AM, Perlman SB, Hinds PW, et al. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Natl Acad Sci U S A 1996;93:6425-30.
54. Schifter T, Hoffman JM, Hanson MW, et al. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumours. J Comput Assist Tomogr 1993;17:509-16.
55. Senekowitsch-Schmidtke R, Matzen K, Truckenbrodt R, et al. Tumor cell spheroids as a model for evaluation of metabolic changes after irradiation. J Nucl Med 1998;39:1762-8.
56. Sheek MR, DesArmier RM, Sagik BP, et al. Biochemical changes during the formation and growth of giant cells from irradiated HeLa cells. Exp Cell Res 1960;19:549-58.
57. 125I-HSA. Eur J Nucl Med 1999;26:333-41.
58. Sviderskaya EV, Jazrawi E, Baldwin SA, et al. Cellular stress causes accumulation of the glucose transporter at the surface of cells independently of their insulin sensitivity. J Membr Biol 1996;149:133-40.
59. 123I] iodo-L-α-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med 2001;42:1144-50.
60. Weckesser M, Griessmeier M, Schmidt D, et al. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumor uptake and extent. Eur J Nucl Med 1998;25:150-6.
61. Weckesser M, Matheja P, Rickert C, et al. Evaluation of the extension of cerebral gliomas by scintigraphy. Strahlenther Onkol 2000;176:180-5.
62. Weckesser M, Matheja P, Schwarzrock A, et al. Prognostic significance of amino acid transport imaging in patients with brain tumors. Neurosurgery 2002;50:958-65.
63. Whitmore GF, Till JE, Gwatkin RBL, et al. Increase of cellular constituents in X-irradiated mammalian cells. Biochim Biophys Acta 1958;30:583-90.
64. Widnell CC, Baldwin SA, Davies A, et al. Cellular stress induces a redistribution of the glucose transporter. FASEB J 1990;4:1634-7.
65. 18F- deoxyglucose. Eur J Nucl Med 1997;24:428-34.
66. Yamada S, Kubota K, Kubota R, et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995;36:1301-6.